ES2123152T3 - Absorcion reducida de acidos grasos. - Google Patents

Absorcion reducida de acidos grasos.

Info

Publication number
ES2123152T3
ES2123152T3 ES94924926T ES94924926T ES2123152T3 ES 2123152 T3 ES2123152 T3 ES 2123152T3 ES 94924926 T ES94924926 T ES 94924926T ES 94924926 T ES94924926 T ES 94924926T ES 2123152 T3 ES2123152 T3 ES 2123152T3
Authority
ES
Spain
Prior art keywords
fatty acids
reduced absorption
absorption
fat
reduced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94924926T
Other languages
English (en)
Inventor
Alun Roy Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kappa Pharmaceuticals Ltd
Original Assignee
Kappa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939317568A external-priority patent/GB9317568D0/en
Priority claimed from GB9403906A external-priority patent/GB9403906D0/en
Application filed by Kappa Pharmaceuticals Ltd filed Critical Kappa Pharmaceuticals Ltd
Application granted granted Critical
Publication of ES2123152T3 publication Critical patent/ES2123152T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A UN AGENTE QUIMICO PARA SU USO EN LA UNION Y LA INSOLUBILIZACION DE LOS PRODUCTOS SOLUBILIZADOS DE DIGESTION DE GRASA PARA EVITAR LA ABSORCION DE LA GRASA DE LA DIETA.
ES94924926T 1993-08-24 1994-08-24 Absorcion reducida de acidos grasos. Expired - Lifetime ES2123152T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939317568A GB9317568D0 (en) 1993-08-24 1993-08-24 Reduced absorption of fatty acids
GB9403906A GB9403906D0 (en) 1994-03-01 1994-03-01 Reduced absorption of fatty acids

Publications (1)

Publication Number Publication Date
ES2123152T3 true ES2123152T3 (es) 1999-01-01

Family

ID=26303415

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94924926T Expired - Lifetime ES2123152T3 (es) 1993-08-24 1994-08-24 Absorcion reducida de acidos grasos.

Country Status (8)

Country Link
US (1) US6093423A (es)
EP (1) EP0714240B1 (es)
JP (1) JP3618348B2 (es)
AU (1) AU685153B2 (es)
DE (1) DE69413544T2 (es)
ES (1) ES2123152T3 (es)
NZ (1) NZ271410A (es)
WO (1) WO1995005752A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267962B1 (en) 1990-12-21 2001-07-31 C-P Technology Limited Partnership Compositions and methods of treatment using peat derivatives
WO1996037207A2 (en) * 1995-05-25 1996-11-28 Biofrontiers, Inc. Pharmaceutical compositions containing calcium sulfate
US5683725A (en) * 1995-05-25 1997-11-04 Biofrontiers, Inc. Modulation of substance P by compounds containing calcium sulfate and methods relating thereto
GB9724840D0 (en) * 1997-11-26 1998-01-21 Kappa Pharmaceuticals Ltd Reduced blood cholesterol
CA2716718A1 (en) * 2010-10-08 2011-09-02 Medicocensus Gmbh Dietary food product with reduced fat absorption

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598375A (en) * 1978-02-17 1981-09-16 Anphar Sa Aluminium magnesium carbonate
US4325975A (en) * 1979-12-31 1982-04-20 Lindon John A Mineralized drinking water and method of making same
DE3402878A1 (de) * 1984-01-27 1985-08-01 Algina AG, Zug Arzneimittel und die verwendung schwerloeslicher calcium- und/oder magnesiumverbindungen als arzneimittel
EP0166440A3 (en) * 1984-06-28 1987-06-03 THE PROCTER & GAMBLE COMPANY Antacid composition
US4780307A (en) * 1984-10-23 1988-10-25 Rafa Laboratories Ltd. Aluminum hydroxide
GB2266217B (en) * 1992-04-16 1995-11-29 Fuji Oil Co Ltd Processes for producing low calorie chocolate having cholesterol reducing effects in blood
WO1994013304A2 (en) * 1992-12-11 1994-06-23 Eastman Kodak Company Antacid composition and method of production

Also Published As

Publication number Publication date
EP0714240A1 (en) 1996-06-05
WO1995005752A1 (en) 1995-03-02
DE69413544T2 (de) 1999-05-27
AU7503094A (en) 1995-03-21
DE69413544D1 (de) 1998-10-29
EP0714240B1 (en) 1998-09-23
JPH09501689A (ja) 1997-02-18
JP3618348B2 (ja) 2005-02-09
AU685153B2 (en) 1998-01-15
NZ271410A (en) 1997-02-24
US6093423A (en) 2000-07-25

Similar Documents

Publication Publication Date Title
AR017873A1 (es) Procedimiento que comprende hacer reaccionar un esterol, un estanol o una combinacion de los mismos con un acido carboxilico o un ester de acido carboxilico en presencia de una cantidad efectiva de un catalizador, una composicion de aditivo para alimentos y metodo para hacerla.
TR27288A (tr) Vitamin ve mineral ilaveleri.
ES2024462B3 (es) Terpolimeros su aplicacion en acondicionadores para el cabello y acondicionadores que los contienen.
ES2184196T3 (es) Dispersiones o suspensiones acuosas.
AR017205A1 (es) ANILIDAS MIMÉTICAS DE ÁCIDO RETINOICO, PROCESOS PARA PREPARAR DICHOS COMPUESTOS, COMPOSICIONES FARMACÉUTICAS QUE LOS COMPRENDEN, UN PROCESO PARA PREPARAR DICHAS COMPOSICIONES Y EL USO DE DICHOS COMPUESTOS EN LA ELABORACIoN DE MEDICAMENTOS.
AU2036088A (en) Hoses stable in length under the effect of an internal pressure
ES2123800T3 (es) Composicion para el cuidado de la piel que contiene vaselina emulsionada.
BR9000188A (pt) Accoplador hidraulico femea,e sistema acoplador
AU3684895A (en) Use of human chorionic gonadotropin as an immune-potentiating agent
FI870808A (fi) 9-alfa, 11-beta-substituerade och 11-beta-substituerade estraner.
IT1277859B1 (it) Linea di trasmissione e procedimento per la sua progettazione.
ES2123152T3 (es) Absorcion reducida de acidos grasos.
BR9607110A (pt) Composição liquida estruturada aquosa e processo para sua preparação
MXPA00012493A (es) Alcoholes de cadena larga suministrados en aceites comestibles.
ES549736A0 (es) Procedimiento para la desinfeccion de petroleo y productos petroliferos
ES2016222A4 (es) Derivados liquidos de grasas naturales y aceites, procedimiento para su elaboracion y utilizacion.
PA8454301A1 (es) Composiciones solubilizadas de sertralina
PT942738E (pt) Esteres de polietilenoglicol de acidos gordos poli-insaturados
DE59000701D1 (de) Axialschubentlastungseinrichtung.
BR9508670A (pt) Bomba para alimento
BR9606963A (pt) Refletor assim como processo e agente para sua preparação
ES1026077Y (es) Dispositivo para la indicacion visual de anomalias de funcionamiento en calderas de pequeña potencia.
ES508609A0 (es) Un procedimiento para la preparacion de soluciones minerales acuosas estables de levonantradol y n-metil-levonantradol.
ES2174176T3 (es) Procedimiento para reducir el daño en tejido asociado con la isquemia.
BR8900956A (pt) Redutor de consumo de combustivel e multiplicador de hp.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 714240

Country of ref document: ES